Diagnosis of exon 12‐positive polycythemia vera rescued by NGS
Open Access
- 21 March 2020
- journal article
- case report
- Published by Wiley in Clinical Case Reports
- Vol. 8 (5) , 790-792
Abstract
A JAK2V617F‐negative polycythemia associated with low serum epo needs to be tested for an exon 12 JAK2 mutation. When negative, due to potential serious complications in PV, a next generation sequencing is necessary to rule out false negative results.Keywords
Funding Information
- Agence Nationale de la Recherche (PRTS 2015 "GenRED")
This publication has 13 references indexed in Scilit:
- Presence of calreticulin mutations in JAK2-negative polycythemia veraBlood, 2014
- A Highly Sensitive Quantitative Real-Time PCR Assay for Determination of Mutant JAK2 Exon 12 Allele BurdenPLOS ONE, 2012
- Nested High-Resolution Melting Curve AnalysisThe Journal of Molecular Diagnostics, 2011
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutationsBlood, 2011
- Failure of the Ipsogen MutaScreen kit to detect the JAK2 617V>F mutation in samples with additional rare exon 14 mutations: implications for clinical testing and report of a novel 618C>F mutation in addition to 617V>FBlood, 2010
- High Resolution Melting Analysis for JAK2 Exon 14 and Exon 12 MutationsThe Journal of Molecular Diagnostics, 2009
- Rapid identification of JAK2 exon 12 mutations using high resolution melting analysisHaematologica, 2008
- The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disordersHaematologica, 2008
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005